greeksoup/ stock research

Chemours (CC) FY2021 results: revenue $6.3 billion, up 27.7% on the year

Chemours Co. (CC) reported revenue of $6.3 billion for fiscal 2021, the year ended 31 December 2021, up 27.7% on the year before. Net income was $608 million, up 177.6%, and diluted earnings per share $3.60. The figures are the company's own, from the 10-K it filed with the SEC on 11 February 2022.

Revenue
$6.3 billion
+27.7% on the year
FY2014FY2021
Operating margin
10.7%
7.4% a year earlier
FY2014FY2021
Net income
$608 million
+177.6% on the year
FY2014FY2021
Diluted EPS
$3.60
+172.7% on the year
FY2014FY2021

this yearthe year beforeHover a bar for its figure.

The year in brief

The quarters: Q3 FY2021 · Q4 FY2021

Income statement (profit and loss)

$ millionFY2021FY2020FY2019On the yearLast 8 years
Revenue6,3454,9695,526+27.7%
Cost of revenue4,9643,9024,463+27.2%
Gross profit1,3811,0671,063+29.4%
Gross margin21.8%21.5%19.2%
Research and development10793.080.0+15.1%
Selling, general and administrative592527548+12.3%
Operating income676367348+84.2%
Operating margin10.7%7.4%6.3%
Interest expense185210208-11.9%
Pre-tax income676179-124+277.7%
Income tax68.0-40.0-72.0
Effective tax rate10.1%-22.3%n/a
Net income608219-52.0+177.6%
Net margin9.6%4.4%-0.9%
Diluted EPS$3.60$1.32-$0.32+172.7%
$ million except per share.
Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.

Cash flow

$ millionFY2021FY2020FY2019On the yearLast 8 years
Operating cash flow814807650+0.9%
Capital expenditure277267481+3.7%
Free cash flow537540169-0.6%
Free cash flow margin8.5%10.9%3.1%
Cash from investing220-234-483
Cash from financing-554-449-419
Depreciation and amortisation317320311-0.9%
Share-based compensation34.016.019.0+112.5%
Buybacks1730.0322
Dividends paid1641641640.0%
Dividend per share$1.00$1.00$1.000.0%
Diluted shares, weighted169m166m165m+1.4%
Shares outstanding at period end161m165m164m-2.3%

Balance sheet

$ millionFY2021FY2020FY2019On the yearLast 8 years
Shareholders' equity1,081813689+33.0%
Non-controlling interest1.02.06.0-50.0%
Debt3,7494,0264,026-6.9%
Operating lease liabilities179194245-7.7%
Finance lease liabilities60.067.054.0-10.4%
Other liabilities2,4801,9802,238+25.3%
Total liabilities and equity7,5507,0827,258+6.6%
Fixed assets3,1543,4743,559-9.2%
Goodwill102153153-33.3%
Intangible assets6.014.021.0-57.1%
Cash and equivalents1,4511,105943+31.3%
Receivables644449602+43.4%
Inventory1,0999391,079+17.0%
Other assets1,094948901+15.4%
Total assets7,5507,0827,258+6.6%

10-K for the year ended 31 December 2021, filed 11 February 2022: the filing.